Usefulness of B-type natriuretic peptide in emergency medicine;Intérêt du dosage des peptides natriurétiques en urgence

Revue de Medecine Interne

Volumn 27, Issue 11, 2006, Pages 858-864

  Ray, P ^a   Lefort, Y ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Centre Hospitalier Departemental Felix Guyon   (France)

Author keywords

Acute dyspnea; B type natriuretic peptide; Emergency department; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

CORRELATION ANALYSIS; DYSPNEA; EMERGENCY MEDICINE; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY;

ACUTE DISEASE; BIOLOGICAL MARKERS; DYSPNEA; EMERGENCY MEDICINE; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 33750472716     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.06.006     Document Type: Short Survey

References (50)

1. Gottdiener J.S., Arnold A.M., Aurigemma G.P., Polak J.F., Tracy R.P., Kitzman D.W., et al. Predictors of congestive heart failure in the elderly: the cardiovascular health study. J. Am. Coll. Cardiol. 35 (2000) 1628-1637
2. Lien C.T., Gillespie N.D., Struthers A.D., and McMurdo M.E. Heart failure in frail elderly patients: diagnostic difficulties, comorbidities, polypharmacy and treatment dilemmas. Eur. J. Heart Fail. 4 (2002) 91-98
3. Davis M., Espiner E., Richards G., Billings J., Town I., Neill A., et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343 (1994) 440-444
4. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347 (2002) 161-167
5. Ray P., Arthaud M., Lefort Y., Birolleau S., Beigelman C., and Riou B. Usefulness of Brain Natriuretic Peptide in elderly patients in acute dyspnea. Intensive Care Med. 30 (2004) 2230-2236
6. Hood S., Taylor S., Roeves A., Crook A.M., Tlusty P., Cohen J., et al. Are there age and sex differences in the investigation and treatment of heart failure? A population-based study. Br. J. Gen. Pract. 50 (2000) 559-563
7. Marantz P.R., Tobin J.N., Derby C.A., and Cohen M.V. Age-associated changes in diastolic filling: Doppler E/A is not associated with congestive heart failure in the elderly. South. Med. J. 87 (1994) 728-735
8. Hermann P.G., Khan A., Kollman C.E., Rojas K.A., Carnody D.P., and Bodenheimer M.M. Limited correlation of left ventricular end diastolic pressure with radiographic assessment of pulmonary hemodynamics. Radiology 174 (1990) 721-724
9. Collins S.P., Ronan-Bentle S., and Storrow A.B. Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea. Ann. Emerg. Med. 41 (2003) 532-545
10. Levin E.R., Gardner D.G., and Samson W.K. Natriuretic peptides. N. Engl. Med. J. 339 (1998) 321-328
11. Clerico A., Del Ry S., Maffei S., Prontera C., Emdin M., and Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effect of age and sex. Clin. Chem. Lab. Med. 40 (2002) 371-377
12. Ray P., Arthaud M., Birolleau S., Isnard R., Lefort Y., Boddaert J., et al. Comparison of brain natriuretic peptide and pro-brain natriuretic peptide, in the diagnosis of cardiogenic pulmonary edema, in patients older than 65 years. J. Am. Geriatr. Soc. 53 (2005) 643-648
13. Mc Cullough P.A., Duc P., Omland T., McCord J., Nowak R., Hollander J., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing not Properly Multinational study. Am. J. Kidney Dis. 41 (2003) 571-579
14. Ten Wolde M., Tulevski I.I., Muldez J.W., Sohne M., Boomsma F., Mulder B., et al. Brain Natriuretic Peptide as a predictor of adverse outcomes in patients with pulmonary embolism. Circulation 107 (2003) 2082-2084
15. de Lemos J.A., Morrow D.A., Gibson C.M., Murphy S.A., Sabatine M.S., Rifai N., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 345 (2001) 1014-1021
16. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J. Am. Coll. Cardiol. 42 (2003) 728-735
17. Cowie M.R., Struthers A.D., Wood D.A., Coats A.J., Thompson S.G., Poole-Wilson P.A., et al. Value of natriuretic peptides in assessments of patients with possible new heart failure in primary care. Lancet 350 (1997) 1347-1350
18. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 95 (2005) 948-954
19. Maisel A.S., Koon J., Krishnaswamy P., Kazenegra R., Clopton P., Gardetto N., et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am. J. Heart 141 (2001) 367-374
20. Lubien E., DeMaria A., Krishnaswamy P., Clopton P., Koon J., Kazanegra R., et al. Utility of B-type natriuretic peptide in detecting diastolic dysfunction. Circulation 105 (2002) 595-602
21. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high-left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am. Heart J. 135 (1998) 825-832
22. Cheng V., Kazanagra R., Garcia A., Lenert L., Krishnaswamy P., Gardetto N., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J. Am. Coll. Cardiol. 37 (2001) 386-391
23. Wuerz R.C., and Meador S.A. Effects of pre hospital medications on mortality and length of stay in congestive heart failure. Ann. Emerg. Med. 21 (1992) 669-674
24. Ray P., Birolleau S., Lefort Y., Becquemin M.-H., Beigelman C., Isnard R., et al. Acute respiratory failure in elderly patients: etiologic diagnostic and prognostic. Critical Care (2006) (sous presse)
25. Cabanes L., Richaud-Thiriez B., Fulla Y., Heloire F., Vuillemard C., Weber S., et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 120 (2001) 2047-2050
26. Morrison K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-Natriuretic Peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J. Am. Coll. Cardiol. 39 (2002) 202-209
27. Dao Q., Krishnaswamy P., Kazanegra R., Harrison A., Amirnovin R., Lenert L., et al. Utility of B-natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J. Am. Coll. Cardiol. 37 (2001) 379-385
28. Logeart D., Saudubray C., Beyne P., Thabut G., Ennezat P.V., Chavelas C., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J. Am. Coll. Cardiol. 40 (2002) 1794-1800
29. Teboul A., Gaffinel A., Meune C., Greffet A., Sauval P., and Carli P. Management of acute dyspnoea: use and feasibility of brain natriuretic peptide (BNP) assay in the prehospital setting. Resuscitation 61 (2004) 91-96
30. Silver M.A., Maisel A., Yancy C.W., McCullough P.A., Burnett Jr. J.C., Francis G.S., et al. Monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest. Heart Fail. 5 Suppl 3 (2004) 1-30
31. Bayes-Genis A., Santalo-Bel M., Zapico-Muniz E., Lopez L., Cotes C., Bellido J., et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur. J. Heart Fail. 6 (2004) 301-308
32. Chenevier-Gobeaux C., Claessens Y.E., Voyer S., Desmoulins D., and Ekindjian O.G. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: Comparison with brain natriuretic peptide (BNP). Clin. Chim. Acta 361 (2005) 167-175
33. Alibay Y., Beauchet A., El Mahmoud R., Schmitt C., Brun-Ney D., Benoit M.O., et al. N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomed. Pharmacother. 59 (2005) 20-24
34. Mueller T., Gegenhuber A., Poelz W., and Haltmayer M. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91 (2005) 606-612
35. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med. 350 (2004) 647-654
36. Maisel A.S., Clopton P., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., et al. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am. Heart J. 147 (2004) 1078-1084
37. Mueller C., Laule-Kilian K., Scholer A., Frana B., Rodriguez D., Schindler C., et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am. J. Cardiol. 94 (2004) 1510-1514
38. Mueller C., Laule-Kilian K., Scholer A., Nusbaumer C., Zeller T., Staub D., et al. B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison. Kidney Int. 67 (2005) 278-284
39. McCullough P.A., Nowak R.M., McCord J., Hollander J.E., Herrmann H.C., Steg P.G., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly Multinational Study. Circulation 106 (2002) 416-422
40. Harrison A., Morrison L.K., Krishnaswamy P., Clopton P., and Maisel A. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann. Emerg. Med. 39 (2002) 131-138
41. Logeart D., Thabut G., Jourdain P., Chavelas C., Beyne P., Beauvais F., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high-risk of readmission after decompensated heart failure. J. Am. Coll. Cardiol. 43 (2004) 635-641
42. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
43. Bassan R., Potsch A., Maisel A., Tura B., Villacorta H., Nogueira M.V., et al. A.B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur. Heart J. 26 (2005) 234-240
44. Kucher N., Printzen G., and Goldhaber S.Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 (2003) 2545-2547
45. Pruszczyk P., Kostrubiec M., Bochowicz A., Styczynski G., Szulc M., Kurzyna, et al. N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism. Eur. Respir. J. 22 (2003) 649-653
46. Ray P., Maziere F., Medimagh S., Lefort Y., Arthaud A., Duguet A., et al. B-type natriuretic as a predictor of complicated pulmonary embolism in the elderly. Am. J. Emerg. Med. (2006) (in press)
47. Burger A.J., Horton D.P., LeJemtel T., Ghali J.K., Torre G., Dennish G., et al. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure the precedent study. Am. Heart J. 144 (2002) 1102-1108
48. Doust J.A., Glasziou P.P., Pietrzak E., and Dobson A.J. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch. Intern. Med. 164 (2004) 1978-1984
49. Clerico A., and Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin. Chem. 50 (2004) 33-50
50. Schwam E. B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal. Acad. Emerg. Med. 11 (2004) 686-691